CohBar, Inc. CWBR

Full chart Compare
Set alert

Price alert · CWBR

All alert types
0.41 0.00 (+0.00%)

At closeJan 16, 2025, 7:00 PM EST

0.41 Day range 0.41

52-week range unavailable

Market cap
2.32M
Shares out
2.91M
Forward P/E
-0.20
Volume
172
Open
0.41
Previous close
0.41
Day's range
0.41 – 0.41
Beta
1.55
Analysts
Hold
Earnings date
Sep 30, 2024

2Y -1.6800 (-80.38%)

0.00002.00004.0000Apr 23Aug 23Jan 24Jun 24Nov 240.4100

Key statistics

Enterprise value
-10.11M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.24
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-3.50M
Total cash
12.31M
Total debt
0
Return on equity
-83.97%
Short % of float
0.52%
50-day average
1.13
200-day average
2.18

Financials — quick view

All financials
CWBR Revenue — quarterly 0
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
CWBR Net income — quarterly -4.33M
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
CWBR EPS — quarterly -1.49
2019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023

Earnings

CWBR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Sep 30, 2024Jun 1, 20240.00———
Jul 1, 2024Mar 1, 20240.00———
Jan 2, 2024Sep 1, 20230.00———
Aug 14, 2023Jun 1, 20230.00-1.39——
May 15, 2023Mar 1, 20230.00-0.75——

About CohBar, Inc.

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
cohbar.com

News

Your note

Sign in to keep a note on CWBR — it syncs with the Stock Master app.

Insider holders

CWBR insider holders
InsiderRelationLatest transactionDateShares held
BIUNNO JEFFREY FRANCISChief Financial OfficerStock Award(Grant)Jul 31, 202257,355
SARRET JOSEPH JChief Executive OfficerStock Award(Grant)Jul 31, 2022151,017

Institution ownership

CWBR institution ownership
Holder% heldSharesValueReported
Quent Capital, LLC5.82%169,177524.45KSep 29, 2023
Vanguard Group Inc0.61%17,66549.28KJun 29, 2023
Geode Capital Management, LLC0.52%15,14342.25KJun 29, 2023
Renaissance Technologies, LLC0.46%13,36037.27KJun 29, 2023
Two Sigma Investments, LP0.45%13,17336.75KJun 29, 2023
Osaic Holdings Inc0.08%2,4596.86KJun 29, 2023

Fund ownership

CWBR fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.61%17,66549.28KJun 29, 2023
Fidelity Extended Market Index Fund0.27%7,77221.06KMay 30, 2023
Fidelity NASDAQ Composite Index Fund0.12%3,5909.73KMay 30, 2023
Fidelity Total Market Index Fund0.07%2,0425.53KMay 30, 2023
Fidelity Series Total Market Index Fund0.04%1,2263.32KMay 30, 2023